
Treace’s mission is to be the recognized leader in the surgical treatment of bunions and foot & ankle conditions. We believe a strong culture of integrity and compliance is critically important to building a world class business and fulfilling our mission.
The Director, Product Marketing – Emerging Foot & Ankle is responsible for strategically planning, implementing, and managing the marketing-related aspects of the company’s emerging foot & ankle product portfolio. This role will lead both long-range strategic planning and short-term tactical execution to drive growth, profitability, and market adoption.
This position is directly responsible for the revenue, profitability, and growth of the emerging foot & ankle portfolio. The Director will bring innovative new foot & ankle products to market, maintain strong relationships with foot & ankle key opinion leaders, and actively support the field sales organization.
The ideal candidate will have deep clinical and commercial experience in reconstructive foot & ankle surgery, including direct operating room case coverage, strong surgeon relationships, and a proven ability to translate unmet clinical needs into successful product and portfolio strategies.
This role requires extensive field travel, including travel to support foot & ankle surgical cases, surgeon meetings, customer engagement activities, sales training, tradeshows, and medical education events.
All your information will be kept confidential according to EEO guidelines.
It is Treace’s policy not to discriminate against any applicant for employment, or any employee because of age, color, sex, disability, national origin, race, religion, veteran status or any other characteristic protected by applicable law. EEO/Disabled/Veterans Employer
Treace is a drug free employer.

Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 67 million Americans1, of which Treace estimates 1.1 million are annual surgical candidates. Treace Medical has pioneered and patented the Lapiplasty® 3D Bunion Correction® system – a combination of instruments, implants, and surgical methods designed to surgically correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause2,3 of the bunion. At Treace Medical Concepts, Inc., our mission is to advance the standard of care for the surgical management of bunions and related midfoot deformities. Treace Medical offers the Adductoplasty® System, the Hammertoe PEEK Fixation System, the SpeedPlate™ System, and other ancillary
The content herein is for informational purposes and intended for healthcare professionals only. Treace Medical Concepts, Inc. does not dispense medical advice. A surgeon should rely on his or her own professional clinical judgment when deciding whether to use a specific product when treating a particular patient. Prior to use of the device, the surgeon should refer to the instructions for use for complete indications, contraindications, warnings, and risks. Complete risk and benefit information: www.treace.com. Visit www.treace.com/privacy-policy for our Privacy Policy.
Treace Medical will make an offer of employment only to individuals who have applied for a position using our official application. Be on alert for possible fraudulent offers of employment. Treace Medical will not solicit money or banking information from applicants.
1Nix S, et al. J Foot Ankle Res. 2010. 27:3:21.
2Dayton P, et al. J Foot Ankle Surg. 2016;55:567-71.
3Dayton P, et al. J Foot Ankle Surg. 2018;57:766-770.